DEF 14A: Focus Universal Seeks Shareholder Approval for Increased Stock Authorization, Director Elections, and Auditor Ratification

Sentiment:

Definitive Proxy Statement


Focus Universal is holding its annual shareholder meeting to vote on key proposals including increasing authorized shares, electing directors, and ratifying the company's auditor.

Capital raiseThe company is seeking approval to increase the number of authorized shares of common stock from 75,000,000 to 150,000,000.The company intends to use the additional shares for raising capital, strategic transactions, and providing equity incentive grants.On or about September 18, 2024, the Company completed the sale of 4,300,000 shares of Common Stock in a private placement to certain eligible investors for an aggregate purchase price of $1,290,000, or $0.30 per share.Dr. Desheng Wang, Chief Executive Officer, Secretary, and Director of the Company entered into a Subscription Agreement pursuant to which the Company agreed to issue and sell 1,000,000 shares of the Companys Common Stock for $300,000 in cash.Dr. Edward Lee, Chairman of the Board of the Company entered into a Subscription Agreement pursuant to which the Company agreed to issue and sell 1,000,000 shares of the Companys Common Stock for $300,000 in cash.

Summary

  • Focus Universal Inc. is soliciting proxies for its 2024 Annual Meeting of Shareholders to be held on November 29, 2024.
  • Shareholders will vote on three key proposals: electing five directors, ratifying the selection of Weinberg & Company, P.A. as the independent auditor, and approving an amendment to increase the authorized shares of common stock from 75,000,000 to 150,000,000.
  • The Board of Directors recommends voting FOR all three proposals.
  • The record date for determining shareholders eligible to vote is October 2, 2024.
  • The company is seeking approval to increase its authorized shares to provide flexibility for future corporate needs, including raising capital and strategic transactions.
  • The Board of Directors consists of five members: Dr. Desheng Wang, Dr. Edward Lee, Michael Pope, Carine Clark, and Sean Warren.
  • The company's independent directors are Michael Pope, Carine Clark, and Sean Warren.
  • The company's executive officers are Dr. Desheng Wang (CEO and Secretary) and Irving Kau (CFO).

Sentiment

Score: 6

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The company is seeking approval for routine matters, but the related party transactions and recent private placement at $0.30 per share introduce some concern.

Positives

  • The proposed increase in authorized shares provides the company with greater flexibility for future financing and strategic opportunities.
  • The Board of Directors is composed of experienced individuals with diverse backgrounds.
  • The company has established committees (Audit, Compensation, and Nominating and Corporate Governance) to oversee key aspects of corporate governance.
  • The company has a Code of Business Conduct and Ethics in place.

Negatives

  • The company has engaged in related party transactions, including loans from shareholders and the CEO.
  • The company's CEO and Chairman are not independent directors.
  • The company has a history of changing auditors, with Weinberg & Company, P.A. being appointed effective January 5, 2024, replacing Reliant CPA PC.

Risks

  • Failure to obtain shareholder approval for the proposed share increase could limit the company's ability to raise capital and pursue strategic transactions.
  • Subsequent issuance of shares of Common Stock, other than on a pro-rata basis to all shareholders, would reduce each shareholders proportionate interest in the Company.
  • The availability of additional authorized shares for issuance may have the effect of discouraging a merger, tender offer, proxy contest, or other attempt to obtain control of the Company.

Future Outlook

The company intends to use the additional authorized shares for various corporate purposes, including raising capital, strategic transactions, and providing equity incentive grants.

Management Comments

  • The Board believes that the Share Increase Proposal is in the Company's best interest because it increases the number of shares of authorized Common Stock by an amount that would provide the Company with flexibility as the need to issue shares of Common Stock may arise in the future for various corporate purposes.

Industry Context

The document does not provide specific industry context beyond the general need for capital and strategic flexibility.

Related Party Transactions

  • Revenue generated from Vitashower Corp., a company owned by the Chief Executive Officer's wife, amounted to $0 and $41,536 for the years ended December 31, 2023 and 2022, respectively.
  • Service revenue generated from the installation of home security equipment by AT Tech and AVX for one of the Company's directors amounted to $65,543 and $8,246 for the years ended December 31, 2023 and 2022, respectively.
  • On September 7, 2023, the Company entered into a loan agreement with Golden Sunrise Investment LLC in the amount of $1,000,000, secured against the Company's property.
  • On April 2, 2024, the Company entered into a two-year loan agreement with the Company's Chief Executive Officer, Desheng Wang, for the amount of $300,000.
  • The Company and Dr. Desheng Wang, Chief Executive Officer, Secretary, and Director of the Company entered into a Subscription Agreement pursuant to which the Company agreed to issue and sell 1,000,000 shares of the Companys Common Stock for $300,000 in cash.
  • The Company and Dr. Edward Lee, Chairman of the Board of the Company entered into a Subscription Agreement pursuant to which the Company agreed to issue and sell 1,000,000 shares of the Companys Common Stock for $300,000 in cash.

Stakeholder Impact

  • Approval of the share increase could dilute existing shareholders' ownership if additional shares are issued.
  • The election of directors will determine the leadership and strategic direction of the company.
  • The ratification of the auditor ensures the integrity of the company's financial reporting.

Next Steps

  • Shareholders to vote on the proposals outlined in the proxy statement.
  • The Board of Directors will determine whether to file the Certificate of Amendment with the Secretary of State of the State of Nevada if the share increase proposal is approved.
  • The company will announce preliminary voting results at the Annual Meeting and publish final results in a Current Report on Form 8-K.

Key Dates

DateDescription
December 29, 2014Dr. Desheng Wang appointed as Chief Executive Officer, Secretary, and Director.
October 21, 2015Dr. Edward Lee appointed President and director of the Company.
June 8, 2018Michael Pope and Carine Clark appointed as independent directors of the Company.
November 1, 2018Dr. Desheng Wang's employment agreement with a salary of $120,000 per year became effective.
August 10, 2022Sean Warren was appointed as an independent director of the Company.
November 18, 2022Irving Kau was appointed as Chief Financial Officer of the Company.
January 5, 2024Weinberg & Company, P.A. was appointed as the independent registered public accounting firm.
October 2, 2024Record Date for determining shareholders entitled to notice of and to vote at the Annual Meeting.
November 29, 2024Date of the Annual Meeting of Shareholders.
December 31, 2024Deadline for shareholders to submit proposals for the 2025 Annual Meeting.

Keywords

proxy statement, annual meeting, shareholders, directors, auditor, authorized shares, common stock, corporate governance, Focus Universal

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.